Despite difficulties years ago, Medtronic plc has opted to pursue a pivotal trial program for its Symplicity Spyral renal denervation system to treat high blood pressure. To that end, it now is slated to start a clinical trial in medicated, uncontrolled hypertension patients, following on a trial initiated earlier this year in unmedicated hypertensive patients.